Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

US KS Kansas City Wilkins H

From Bioblast

                



US KS Kansas City Wilkins H

Oroboros O2k-Network

O2k-Network
O2k-Network Lab Hemenway at University of Kansas Medical Center, Department of Neurology, University of Kansas Alzheimer’s Disease Center
Address 2106 Olathe Blvd Bldg 64 Room 1039, 66109
City Kansas City
State/Prov Kansas (KS)
Country USA
Weblink
Contact Wilkins Heather M
Team
Team previous
Status O2k 2019-
Oroboros Events
Topics Alzheimer’s Disease, brain bioenergetics


O2k-Publications

 PublishedReference
Taylor 2024 Pilot Feasibility Stud2024Taylor MK, Burns JM, Choi IY, Herda TJ, Lee P, Smith AN, Sullivan DK, Swerdlow RH, Wilkins HM (2024) Protocol for a single-arm, pilot trial of creatine monohydrate supplementation in patients with Alzheimer's disease. Pilot Feasibility Stud 10:42. https://doi.org/10.1186/s40814-024-01469-5
Tungtur 2021 Sci Rep2021Tungtur SK, Wilkins HM, Rogers RS, Badawi Y, Sage JM, Agbas A, Jawdat O, Barohn RJ, Swerdlow RH, Nishimune H (2021) Oxaloacetate treatment preserves motor function in SOD1G93A mice and normalizes select neuroinflammation-related parameters in the spinal cord. Sci Rep 11:11051.

O2k-Abstracts

update please